Determining the pharmacokinetics and long-term biodistribution of SiO2 nanoparticles in vivo using accelerator mass spectrometry.
about
In Vitro/In Vivo Toxicity Evaluation and Quantification of Iron Oxide Nanoparticles.Use of Accelerator Mass Spectrometry in Human Health and Molecular ToxicologyNew surface radiolabeling schemes of super paramagnetic iron oxide nanoparticles (SPIONs) for biodistribution studiesOptimizing nanomedicine pharmacokinetics using physiologically based pharmacokinetics modelling.Tissue distribution and excretion kinetics of orally administered silica nanoparticles in rats.Nonporous Silica Nanoparticles for Nanomedicine Application.Drug-loadable Mesoporous Bioactive Glass Nanospheres: Biodistribution, Clearance, BRL Cellular Location and Systemic Risk Assessment via (45)Ca Labelling and Histological AnalysisClearance Pathways and Tumor Targeting of Imaging NanoparticlesMaternal exposure to an environmentally relevant dose of triclocarban results in perinatal exposure and potential alterations in offspring development in the mouse model.The biodistribution and pharmacokinetics of the oxime acetylcholinesterase reactivator RS194B in guinea pigs.Silica dioxide nanoparticles combined with cold exposure induce stronger systemic inflammatory response.
P2860
Q26779017-8A9994A5-0AD4-4972-B59E-AA8D5C6ACD6BQ28818313-DB42017D-FDDC-47B5-926B-52F705EDD641Q28834078-C810D53F-6477-4D38-B6DB-085534EA3413Q34571360-52AFB0AB-7729-4823-936F-AE5CE2BD4147Q34787883-66457A5F-5ADD-4DD4-97DF-29624919A696Q37131939-B621B8BB-C4A5-48E2-92F4-28AE582A4608Q37257634-C6A77D68-D310-44CB-BE42-17EF1E09B8B3Q38543331-CFE2A038-CBD2-432F-AE4A-3C284ADE83D0Q38632251-A0B5E2DE-F74A-45B9-B726-DB5206E4F11FQ46950790-F8BDDAC3-0600-48AB-9347-0AE501E20D5AQ50283357-57048F0A-D227-4CB7-AA02-C357BE7FE862
P2860
Determining the pharmacokinetics and long-term biodistribution of SiO2 nanoparticles in vivo using accelerator mass spectrometry.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
Determining the pharmacokineti ...... accelerator mass spectrometry.
@ast
Determining the pharmacokineti ...... accelerator mass spectrometry.
@en
type
label
Determining the pharmacokineti ...... accelerator mass spectrometry.
@ast
Determining the pharmacokineti ...... accelerator mass spectrometry.
@en
prefLabel
Determining the pharmacokineti ...... accelerator mass spectrometry.
@ast
Determining the pharmacokineti ...... accelerator mass spectrometry.
@en
P2093
P2860
P356
P1433
P1476
Determining the pharmacokineti ...... accelerator mass spectrometry.
@en
P2093
Edward A Kuhn
Heather A Palko
Kenneth W Turteltaub
Michael A Malfatti
P2860
P304
P356
10.1021/NL302412F
P407
P577
2012-10-17T00:00:00Z